• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻风分枝杆菌脱脂细胞成分对小鼠感染麻风杆菌的体内作用。

In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.

作者信息

Damle A, Mahadevan P R

机构信息

Radiation Medicine Centre, Parel, Bombay.

出版信息

Indian J Lepr. 1993 Jul-Sep;65(3):271-82.

PMID:8283062
Abstract

The delipidified cell component (DCC) of Mycobacterium leprae was used as an immunomodulatory agent in Swiss white mice. The peritoneal macrophages of these mice were activated to produce increased amount of reactive oxygen intermediates like hydrogen peroxide (H2O2) and superoxide. These macrophages also attained the ability to kill M. Leprae in vitro as shown by several assay systems including the conventional mouse foot-pad technique. The increased levels of superoxide seem to be responsible for the killing of M. leprae as addition of the enzyme superoxide dismutase, which breaks down O2, resulted in survival of these bacilli inside the macrophages. The increased production of H2O2 does not seem to be responsible for killing M. leprae. The results indicate that the DCC of M. leprae acts as an effective immunomodulator in mice leading to the activation of macrophages with increased production of H2O2 and superoxide as well as enabling them to kill M. leprae via the action of superoxide anions.

摘要

麻风分枝杆菌的脱脂细胞成分(DCC)被用作瑞士小白鼠的免疫调节剂。这些小鼠的腹腔巨噬细胞被激活,产生更多的活性氧中间体,如过氧化氢(H2O2)和超氧化物。这些巨噬细胞在体外也获得了杀死麻风分枝杆菌的能力,包括传统的小鼠足垫技术在内的几种检测系统都证明了这一点。超氧化物水平的升高似乎是杀死麻风分枝杆菌的原因,因为添加分解O2的超氧化物歧化酶会导致这些杆菌在巨噬细胞内存活。H2O2产量的增加似乎不是杀死麻风分枝杆菌的原因。结果表明,麻风分枝杆菌的DCC在小鼠中作为一种有效的免疫调节剂,导致巨噬细胞被激活,H2O2和超氧化物的产生增加,并使它们能够通过超氧阴离子的作用杀死麻风分枝杆菌。

相似文献

1
In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.麻风分枝杆菌脱脂细胞成分对小鼠感染麻风杆菌的体内作用。
Indian J Lepr. 1993 Jul-Sep;65(3):271-82.
2
Reactive oxygen intermediates inactivate Mycobacterium leprae in the phagocytes from human peripheral blood.活性氧中间体可使人类外周血吞噬细胞中的麻风分枝杆菌失活。
Int J Lepr Other Mycobact Dis. 1989 Jun;57(2):483-91.
3
Nature of peritoneal macrophages from DCC immunized mice.
Indian J Lepr. 1993 Oct-Dec;65(4):405-14.
4
Delipidified cell components of Mycobacterium leprae and its applications.麻风分枝杆菌的脱脂细胞成分及其应用。
Indian J Lepr. 1991 Jul-Dec;63(3-4):371-87.
5
The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum.在用麻风分枝杆菌和海分枝杆菌感染足垫的小鼠中存在全身和局部活化的巨噬细胞。
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):206-15.
6
Viability of Mycobacterium leprae inside macrophages from different strains of mice and possible genetic control.麻风分枝杆菌在不同品系小鼠巨噬细胞内的生存能力及可能的基因控制
Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):548-53.
7
Macrophage activity in Mycobacterium leprae infection.麻风分枝杆菌感染中的巨噬细胞活性
Acta Leprol. 1984 Oct-Dec;2(2-4):259-66.
8
An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae--the probable molecular events identified by in vitro experiments.一种能恢复麻风病患者杀灭麻风分枝杆菌能力的抗原复合物——体外实验确定的可能分子事件。
Trop Med Parasitol. 1990 Sep;41(3):310-3.
9
A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients.麻风分枝杆菌的一种成分作为麻风病患者免疫缺陷细胞的免疫调节因子。
J Clin Lab Immunol. 1987 Dec;24(4):171-6.
10
Antigenic protein from Mycobacterium leprae released in macrophages in vitro as indicator of viability of bacteria.体外巨噬细胞中释放的麻风分枝杆菌抗原蛋白作为细菌活力的指标。
Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):540-7.

引用本文的文献

1
Role of NADPH oxidase in formation and function of multinucleated giant cells.NADPH 氧化酶在多核巨细胞形成和功能中的作用。
J Innate Immun. 2009;1(6):509-26. doi: 10.1159/000228158. Epub 2009 Jul 7.